These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9689453)

  • 1. A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats.
    Picazo O; Fernández-Guasti A; Lemus AE; García GA
    Brain Res; 1998 Jun; 796(1-2):45-52. PubMed ID: 9689453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test.
    Picazo O; Fernández-Guasti A
    Brain Res; 1995 May; 680(1-2):135-41. PubMed ID: 7663969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents.
    Pasapera AM; Camacho-Arroyo I; Savouret JF; García GA; Pérez-Palacios G; Pichon C; Cerbón MA
    Arch Med Res; 1995; 26 Spec No():S203-7. PubMed ID: 8845651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites.
    Enríquez J; Lemus AE; Chimal-Monroy J; Arzate H; García GA; Herrero B; Larrea F; Pérez-Palacios G
    J Endocrinol; 2007 Jun; 193(3):493-504. PubMed ID: 17535886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimodal binding and free energy of the progesterone receptor in the induction of female sexual receptivity by progesterone and synthetic progestins.
    Kubli-Garfias C; González-Flores O; Gómora-Arrati P; González-Mariscal G; Vázquez-Ramírez R; Beyer C
    J Steroid Biochem Mol Biol; 2013 Jan; 133():43-50. PubMed ID: 22960752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual differentiation modifies the allopregnanolone anxiolytic actions in rats.
    Fernández-Guasti A; Picazo O
    Psychoneuroendocrinology; 1999 Apr; 24(3):251-67. PubMed ID: 10101732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level.
    Pérez-Palacios G; Cerbón MA; Pasapera AM; Castro JI; Enríquez J; Vilchis F; García GA; Moralí G; Lemus AE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):479-85. PubMed ID: 1562519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the post-ovariectomy time frame on the experimental anxiety and the behavioural actions of some anxiolytic agents.
    Picazo O; Estrada-Camarena E; Hernandez-Aragon A
    Eur J Pharmacol; 2006 Jan; 530(1-2):88-94. PubMed ID: 16356491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flumazenil blocks the anxiolytic action of allopregnanolone.
    Fernández-Guasti A; Picazo O
    Eur J Pharmacol; 1995 Jul; 281(1):113-5. PubMed ID: 8566110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
    Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
    Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid anxiolytic activity of progesterone and pregnanolone in male rats.
    Gomez C; Saldivar-Gonzalez A; Delgado G; Rodriguez R
    Pharmacol Biochem Behav; 2002 Jun; 72(3):543-50. PubMed ID: 12175450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
    Hager SR; Kalkhoff RK
    Horm Metab Res; 1990 May; 22(5):265-8. PubMed ID: 2112109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of levonorgestrel: in vitro metabolism and specific interactions with steroid receptors in target organs.
    Lemus AE; Vilchis F; Damsky R; Chávez BA; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):881-90. PubMed ID: 1562565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms in progestin antagonism of pituitary tumorigenesis.
    Piroli G; Torres A; Grillo C; Lux-Lantos V; Aoki A; De Nicola AF
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):59-67. PubMed ID: 9569011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats.
    Laconi MR; Casteller G; Gargiulo PA; Bregonzio C; Cabrera RJ
    Eur J Pharmacol; 2001 Apr; 417(1-2):111-6. PubMed ID: 11301065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum.
    Bitran D; Dugan M; Renda P; Ellis R; Foley M
    Brain Res; 1999 Dec; 850(1-2):217-24. PubMed ID: 10629767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
    García-Becerra R; Cooney AJ; Borja-Cacho E; Lemus AE; Pérez-Palacios G; Larrea F
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):21-7. PubMed ID: 15261304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of desipramine with steroid hormones on experimental anxiety.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C; Contreras CM; Fernández-Guasti A
    Psychoneuroendocrinology; 2000 Feb; 25(2):109-20. PubMed ID: 10674276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration with levonorgestrel decreases allopregnanolone levels and alters GABA(A) receptor subunit expression and anxiety-like behavior.
    Porcu P; Mostallino MC; Sogliano C; Santoru F; Berretti R; Concas A
    Pharmacol Biochem Behav; 2012 Aug; 102(2):366-72. PubMed ID: 22634062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.